Millipore Announces Collaboration with Abeome Corporation
28 Nov 2007Millipore Corporation, a Life Science leader providing technologies, tools and services for the bioscience research and biopharmaceutical manufacturing industry, today announced its collaboration with Abeome Corporation on the development and distribution of a novel stem cell antibody. The antibody, Human Embryonic Stem Cell Antigen-1 (HESCA-1), is a previously unidentified marker for the analysis of pluripotent stem cells in immunocytochemistry and other immunological techniques.
This unique antibody was developed by Abeome in conjunction with Novocell, Inc., and Millipore will market and distribute HESCA-1 to the research community. HESCA-1 targets a cell surface protein that is potentially a unique antigen expressed by human embryonic stem cells. The antigen is present in five hES cell lines, but does not appear to be expressed on differentiated or feeder cell types. With further research, HESCA-1 may prove useful in the development of therapies for human cancers and other debilitating diseases.
“HESCA-1 highlights Millipore’s commitment to providing innovative tools for the advancement of human embryonic stem cell research,” states Donald O’Neil, director of marketing for stem cells and cell biology at Millipore. “This demonstrates yet another example of our strategy to provide the most complete integrated stem cell offering, cutting across the entire stem cell workflow.”
Established in 1954 as a high performance filtration products and services company, Millipore has grown into a partner for Life Science customers through R&D investment, organic growth and acquisitions. Companies acquired include Chemicon®, Upstate®, Linco®, and NovaSeptic® AB. The integrated Millipore offers you more innovative technologies and stronger application support to streamline your progress and give you more confidence in your results. Our expert team of scientists understands the complexity of Life Science research and can support our customers in their most difficult challenges in cell biology, stem cells, protein research, and cell signaling.